Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schmid John P.
Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SHERMAN JEFFREY W
Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Kong Garheng
Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director JOHNSON JOHN
Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director JOHNSON JOHN
Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schmid John P.
Xeris Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-The Vanguard Group(5.13%)
Xeris Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Stonepine Capital Management, LLC(4.3%),Stonepine Capital, L.P(4.3%), etc.
Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Hecht Beth
Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer JOHNSON KENNETH ERLAND
Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shannon John Patrick Jr
Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Pieper Steven
Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Edick Paul R
Xeris Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(7.2%)
Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SHERMAN JEFFREY W
Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HALKUFF DAWN
Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Pieper Steven
Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schmid John P.
Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shannon John Patrick Jr
Xeris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director PERSKY MARLA
No Data